ask="0.7000"
ask_size="1000"
average_daily_volume="124216"
bid="N/A"
bid_size="N/A"
book_value="0.7250"
change="+0.0217"
change_from_200_day_moving_average="-0.6718"
change_from_50_day_moving_average="-0.5188"
change_from_52_week_high="-1.3003"
change_From_52_week_low="0.0497"
change_in_percent="+3.2006%"
close="0.6997"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.8700"
eps_estimate_next_quarter="-0.2100"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30554000"
high="0.7200"
high_52_weeks="2.0000"
last_trade_date="2/15/2017"
last_trade_price="0.6997"
last_trade_size="2623"
last_trade_time="4:00pm"
low="0.6700"
low_52_weeks="0.6500"
market_capitalization="27.04M"
moving_average_200_day="1.3715"
moving_average_50_day="1.2185"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.7000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-48.9836%"
percent_change_from_50_day_moving_average="-42.5784%"
percent_change_from_52_week_high="-65.0150%"
percent_change_from_52_week_low="+7.6462%"
previous_close="0.6780"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.9352"
price_per_sales="2.6739"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.3700"
stock_exchange="NMS"
symbol="AVIR"
volume="333088"
weeks_range_52="0.6500 - 2.0000"
